Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy trial (ORIENT): Rationale and study design

Enyu Imai, Sadayoshi Ito, Masakazu Haneda, Juliana C.N. Chan, Hirofumi Makino

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Fingerprint Dive into the research topics of 'Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy trial (ORIENT): Rationale and study design'. Together they form a unique fingerprint.

Medicine & Life Sciences